Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics, 1st ed. 2019 Springer Theses Series
This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management.- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout.- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets.- Amplification-Free Electrochemical RNA Biomarker Sensing.- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.
Date de parution : 10-2020
Ouvrage de 102 p.
15.5x23.5 cm
Date de parution : 10-2019
Ouvrage de 102 p.
15.5x23.5 cm
Thèmes d’Advancing Gene Fusion Detection Towards Personalized... :
Mots-clés :
Prostate Cancer Detection; Precision Medicine; Urinary Nanodiagnostics; Clinical Translation; Biosensor Development; Next-generation Prostate Cancer Biomarkers; Non-invasive Prostate Cancer Nanodiagnostics; TMPRSS2–ETS Fusion Genes; Electro Chemistry; Surface-enhanced Raman spectroscopy; Enhanced Detection Performance; Nanodiagnostics for Clinical Applications; Lab-in-a-drop; Fluidic Mixing